Genomma Lab Internacional, S.A.B. de C.V GNMLF Stock
Genomma Lab Internacional, S.A.B. de C.V Price Chart
Genomma Lab Internacional, S.A.B. de C.V GNMLF Financial and Trading Overview
Contents
| Genomma Lab Internacional, S.A.B. de C.V stock price | 0.84 USD |
| Previous Close | 0.84 USD |
| Open | 0.95 USD |
| Bid | 0.78 USD x 100000 |
| Ask | 0.86 USD x 200000 |
| Day's Range | 0.95 - 0.95 USD |
| 52 Week Range | 0.84 - 1.17 USD |
| Volume | 5K USD |
| Avg. Volume | 258 USD |
| Market Cap | 928.87M USD |
| Beta (5Y Monthly) | 0.146 |
| PE Ratio (TTM) | 9.5 |
| EPS (TTM) | 0.1 USD |
| Forward Dividend & Yield | 0.05 (5.54%) |
| Ex-Dividend Date | June 26, 2026 |
| 1y Target Est | N/A |
GNMLF Valuation Measures
| Enterprise Value | 6.34B USD |
| Trailing P/E | 9.5 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 0.46 |
| Price/Sales (ttm) | 0.05361274 |
| Price/Book (mrq) | 1.3696479 |
| Enterprise Value/Revenue | 0.366 |
| Enterprise Value/EBITDA | 1.568 |
Trading Information
Genomma Lab Internacional, S.A.B. de C.V Stock Price History
| Beta (5Y Monthly) | 0.146 |
| 52-Week Change | -26.31% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 1.17 USD |
| 52 Week Low | 0.84 USD |
| 50-Day Moving Average | 1.06 USD |
| 200-Day Moving Average | 1.03 USD |
GNMLF Share Statistics
| Avg. Volume (3 month) | 258 USD |
| Avg. Daily Volume (10-Days) | 1K USD |
| Shares Outstanding | 977.75M |
| Float | 672.78M |
| Short Ratio | N/A |
| % Held by Insiders | 30.93% |
| % Held by Institutions | 32.35% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.6 |
| Trailing Annual Dividend Yield | 71.42% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.48610002 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 9.25% |
| Operating Margin (ttm) | 20.86% |
| Gross Margin | 62.98% |
| EBITDA Margin | 23.35% |
Management Effectiveness
| Return on Assets (ttm) | 9.39% |
| Return on Equity (ttm) | 14.04% |
Income Statement
| Revenue (ttm) | 17.33B USD |
| Revenue Per Share (ttm) | 17.82 USD |
| Quarterly Revenue Growth (yoy) | -4.90% |
| Gross Profit (ttm) | 10.91B USD |
| EBITDA | 4.05B USD |
| Net Income Avi to Common (ttm) | 1.6B USD |
| Diluted EPS (ttm) | 0.1 |
| Quarterly Earnings Growth (yoy) | -0.80% |
Balance Sheet
| Total Cash (mrq) | 2.63B USD |
| Total Cash Per Share (mrq) | 2.7 USD |
| Total Debt (mrq) | 8.16B USD |
| Total Debt/Equity (mrq) | 69.65 USD |
| Current Ratio (mrq) | 1.387 |
| Book Value Per Share (mrq) | 0.69360894 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.98B USD |
| Levered Free Cash Flow (ttm) | 436.12M USD |
Profile of Genomma Lab Internacional, S.A.B. de C.V
| Country | United States |
| State | DF |
| City | Mexico City |
| Address | Avenida Antonio Dovalí Jaime No. 70 |
| ZIP | 01210 |
| Phone | 52 55 5081 0000 |
| Website | https://www.genommalab.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1643 |
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.
Q&A For Genomma Lab Internacional, S.A.B. de C.V Stock
What is a current GNMLF stock price?
Genomma Lab Internacional, S.A.B. de C.V GNMLF stock price today per share is 0.84 USD.
How to purchase Genomma Lab Internacional, S.A.B. de C.V stock?
You can buy GNMLF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genomma Lab Internacional, S.A.B. de C.V?
The stock symbol or ticker of Genomma Lab Internacional, S.A.B. de C.V is GNMLF.
Which industry does the Genomma Lab Internacional, S.A.B. de C.V company belong to?
The Genomma Lab Internacional, S.A.B. de C.V industry is Drug Manufacturers - Specialty & Generic.
How many shares does Genomma Lab Internacional, S.A.B. de C.V have in circulation?
The max supply of Genomma Lab Internacional, S.A.B. de C.V shares is 977.75M.
What is Genomma Lab Internacional, S.A.B. de C.V Price to Earnings Ratio (PE Ratio)?
Genomma Lab Internacional, S.A.B. de C.V PE Ratio is 8.36800000 now.
What was Genomma Lab Internacional, S.A.B. de C.V earnings per share over the trailing 12 months (TTM)?
Genomma Lab Internacional, S.A.B. de C.V EPS is 0.1 USD over the trailing 12 months.
Which sector does the Genomma Lab Internacional, S.A.B. de C.V company belong to?
The Genomma Lab Internacional, S.A.B. de C.V sector is Healthcare.